iPower Restates 2020 Equity Incentive Plan
iPower Inc. filed an exhibit amending and restating its 2020 Equity Incentive Plan, which outlines the grant of stock and cash awards. This regulatory filing impacts corporate gove…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
iPower Inc. filed an exhibit amending and restating its 2020 Equity Incentive Plan, which outlines the grant of stock and cash awards. This regulatory filing impacts corporate gove…
bioAffinity Technologies will present data on its CyPath Lung diagnostic system at NAVREF, demonstrating benefits in clinical practice and for veteran populations. The conference h…
Idaho Copper received U.S. Forest Service approval to commence drilling at its CuMo copper-molybdenum project, clearing a major regulatory hurdle for continued development.
Compass Therapeutics (CMPX) received FDA feedback requesting a new study to demonstrate survival benefits before allowing a Biologics License Application (BLA) for tovecimig in bil…
PDS Biotech announced publication of VERSATILE-002 results showing 39.3 months median overall survival, beating published benchmarks for HPV16-positive Head and Neck Cancer.
Filana Therapeutics announced the FDA has lifted the clinical hold on the simufilam IND, allowing the planned Phase 2a trial to begin screening in early 2027. This regulatory devel…
Vice President of Exploration Dave Larimer consented to the release of the Kitsault Valley Project Technical Report Summary and Updated Mineral Resource Estimate. Larimer's involve…
Celldex's barzolvolimab met primary and all secondary endpoints in Phase 3 trials for chronic spontaneous urticaria, leading to a potential FDA BLA submission in 2027.
Store Capital announced the formation of three new master funding entities and filed an exhibit detailing an amended and restated indenture for October 2025 senior unsecured notes.…
The company amended its articles to extend the combination deadline to March 2027 and modified governing provisions for share issuance and redemption. The extension aims to provide…
The company amended its certificate of incorporation to increase total authorized capital stock to 125.35 million shares, including 125 million common shares and additional preferr…
Seneca Foods amended its certificate of incorporation to reduce designated shares of preferred stock, delete an entire series, and change its legal address. The filing reflects aut…
MNP LLP provided consent to incorporate its audit report into certain registration statements. The firm is engaged as the auditor for Silver47 Exploration Corp.
The company filed an amended and restated certificate of incorporation, amending its authorized number of shares to be issued and other corporate actions. This regulatory filing is…
The FDA issued a direct final rule allowing non-animal methods to replace animal testing for drug safety where appropriate. This updates regulations regarding pre-human testing for…
Trilogy Metals' Arctic copper-zinc-lead-gold-silver project initiates NEPA review with a notice to prepare an Environmental Impact Statement, marking a key permitting milestone for…
Evolution Metals & Technologies Corp. was added to both the Russell 2000 and 3000 indexes on Sept 21, exposing the company to $12.2 trillion in benchmarked assets and expanding its…
Cue Biopharma reported successful Phase 2 results in chronic spontaneous urticaria, meeting primary endpoints with statistical significance and demonstrating a favorable safety pro…
StoneBridge Acquisition II Corp. filed an annual information statement for the taxable year ended Dec. 31, 2025, for potential U.S. shareholders to elect to be treated as a qualifi…
Alkermes announced a Phase 1b study of ALKS 7290 demonstrated clinically meaningful, dose-dependent improvements in ADHD symptoms in adult patients, highlighting potential for diff…